Plasmacytoid dendritic cells and C1q differentially regulate inflammatory gene induction by lupus immune complexes

Journal of Immunology

Volumn 188, Issue 2, 2012, Pages 902-915

  Santer, Deanna M ^a   Wiedeman, Alice E ^a   Teal, Thomas H ^a   Ghosh, Pradipta ^a   Elkon, Keith B ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; COMPLEMENT COMPONENT C1Q; INTERFERON; RNA;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE INDUCTION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE SUBPOPULATION; MICROARRAY ANALYSIS; MONOCYTE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; UNINDEXED SEQUENCE;

ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, CD14; COMPLEMENT C1Q; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MONOCYTES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 84856022097     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102797     Document Type: Article

References (71)

1. Tan, E. M. 1989. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44: 93-151. (Pubitemid 19090837)
2. Hahn, B. H. 1998. Antibodies to DNA. N. Engl. J. Med. 338: 1359-1368. (Pubitemid 28216666)
3. Koffler, D., V. Agnello, R. Thoburn, and H. G. Kunkel. 1971. Systemic lupus erythematosus: prototype of immune complex nephritis in man. J. Exp. Med. 134: 169-179.
4. Ravetch, J. V., and S. Bolland. 2001. IgG Fc receptors. Annu. Rev. Immunol. 19: 275-290. (Pubitemid 32368037)
5. Baatrup, G. 1989. Immune complex modulation by plasma proteins: with special reference to the complement system and autoimmune diseases. Dan. Med. Bull. 36: 443-463.
6. Botto, M., and M. J. Walport. 2002. C1q, autoimmunity and apoptosis. Immunobiology 205: 395-406. (Pubitemid 35153956)
7. Carroll, M. C. 1998. The lupus paradox. Nat. Genet. 19: 3-4. (Pubitemid 28242011)
8. Mevorach, D., J. O. Mascarenhas, D. Gershov, andK. B. Elkon. 1998.Complementdependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 188: 2313-2320. (Pubitemid 29028503)
9. Botto, M., C. Dell'Agnola, A. E. Bygrave, E. M. Thompson, H. T. Cook, F. Petry, M. Loos, P. P. Pandolfi, and M. J. Walport. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19: 56-59. (Pubitemid 28242023)
10. Walport, M. J. 2000. Lupus, DNase and defective disposal of cellular debris. Nat. Genet. 25: 135-136. (Pubitemid 30394978)
11. Bao, L., I. Osawe, T. Puri, J. D. Lambris, M. Haas, and R. J. Quigg. 2005. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. Eur. J. Immunol. 35: 2496-2506. (Pubitemid 41179771)
12. Biesecker, G., and D. Koffler. 1982. Immunopathology of the membrane attack complex in systemic lupus erythematosus nephritis. Arthritis Rheum. 25: 876-879. (Pubitemid 12022167)
13. Given, W. P., H. S. Edelson, H. B. Kaplan, P. Aisen, G. Weissmann, and S. B. Abramson. 1984. Generation of C5-derived peptides and other immune reactants in the sera of patients with systemic lupus erythematosus. Arthritis Rheum. 27: 631-637. (Pubitemid 14089472)
14. Lood, C., B. Gullstrand, L. Truedsson, A. I. Olin, G. V. Alm, L. Rönnblom, G. Sturfelt, M. L. Eloranta, and A. A. Bengtsson. 2009. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. Arthritis Rheum. 60: 3081-3090.
15. Santer, D. M., B. E. Hall, T. C. George, S. Tangsombatvisit, C. L. Liu, P. D. Arkwright, and K. B. Elkon. 2010. C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes. J. Immunol. 185: 4738-4749.
16. Tan, E. M., A. S. Cohen, J. F. Fries, A. T. Masi, D. J. McShane, N. F. Rothfield, J. G. Schaller, N. Talal, and R. J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277. (Pubitemid 13221242)
17. Cros, J., N. Cagnard, K. Woollard, N. Patey, S. Y. Zhang, B. Senechal, A. Puel, S. K. Biswas, D. Moshous, C. Picard, et al. 2010. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 33: 375-386.
18. Lövgren, T., M. L. Eloranta, B. Kastner, M. Wahren-Herlenius, G. V. Alm, and L. Rönnblom. 2006. Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA. Arthritis Rheum. 54: 1917-1927. (Pubitemid 43877941)
19. Santer, D. M., T. Yoshio, S. Minota, T. Möller, and K. B. Elkon. 2009. Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus. J. Immunol. 182: 1192-1201.
20. Dzionek, A., Y. Sohma, J. Nagafune, M. Cella, M. Colonna, F. Facchetti, G. Günther, I. Johnston, A. Lanzavecchia, T. Nagasaka, et al. 2001. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 194: 1823-1834. (Pubitemid 34028661)
21. Du, P., W. A. Kibbe, and S. M. Lin. 2008. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24: 1547-1548. (Pubitemid 351911712)
22. Guiducci, C., M. Gong, Z. Xu, M. Gill, D. Chaussabel, T. Meeker, J. H. Chan, T. Wright, M. Punaro, S. Bolland, et al. 2010. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature 465: 937-941.
23. Kuri, T., X. Zhang, M. Habjan, L. Martínez-Sobrido, A. García-Sastre, Z. Yuan, and F. Weber. 2009. Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation. J. Gen. Virol. 90: 2686-2694.
24. Miyashita, M., H. Oshiumi, M. Matsumoto, and T. Seya. 2011. DDX60, a DEXD/H box helicase, is a novel antiviral factor promoting RIG-I-like receptor- mediated signaling. Mol. Cell. Biol. 31: 3802-3819.
25. Pos, Z., S. Selleri, T. L. Spivey, J. K. Wang, H. Liu, A. Worschech, M. Sabatino, A. Monaco, S. F. Leitman, A. Falus, et al. 2010. Genomic scale analysis of racial impact on response to IFN-alpha. Proc. Natl. Acad. Sci. USA 107: 803-808.
26. van Baarsen, L. G., C. A.Wijbrandts, F. Rustenburg, T. Cantaert, T. C. van der Pouw Kraan, D. L.Baeten, B. A. Dijkmans, P. P. Tak, and C. L. Verweij. 2010. Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment. Arthritis Res. Ther. 12: R11.
27. Waddell, S. J., S. J. Popper, K. H. Rubins, M. J. Griffiths, P. O. Brown, M. Levin, and D. A. Relman. 2010. Dissecting interferon-induced transcriptional programs in human peripheral blood cells. PLoS One 5: e9753.
28. Yan, W., H. Lee, E. C. Yi, D. Reiss, P. Shannon, B. K. Kwieciszewski, C. Coito, X. J. Li, A. Keller, J. Eng, et al. 2004. System-based proteomic analysis of the interferon response in human liver cells. Genome Biol. 5: R54.
29. Zimmerer, J. M., G. B. Lesinski, A. S. Ruppert, M. D. Radmacher, C. Noble, K. Kendra, M. J. Walker, and W. E. Carson, III. 2008. Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-alpha. Clin. Cancer Res. 14: 5900-5906.
30. Samarajiwa, S. A., S. Forster, K. Auchettl, and P. J. Hertzog. 2009. INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res. 37 (Database issue): D852-D857.
31. Finke, D., M. L. Eloranta, and L. Rönnblom. 2009. Endogenous type I interferon inducers in autoimmune diseases. Autoimmunity 42: 349-352.
32. Båve, U., M. Magnusson, M. L. Eloranta, A. Perers, G. V. Alm, and L. Rönnblom. 2003. Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. J. Immunol. 171: 3296-3302. (Pubitemid 37093557)
33. Lövgren, T., M. L. Eloranta, U. Båve, G. V. Alm, and L. Rönnblom. 2004. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 50: 1861-1872. (Pubitemid 38725099)
34. Vollmer, J., S. Tluk, C. Schmitz, S. Hamm, M. Jurk, A. Forsbach, S. Akira, K. M. Kelly, W. H. Reeves, S. Bauer, and A. M. Krieg. 2005. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J. Exp. Med. 202: 1575-1585. (Pubitemid 41746603)
35. Salmon, J. E., and L. Pricop. 2001. Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. Arthritis Rheum. 44: 739-750. (Pubitemid 32319766)
36. Takai, T. 2002. Roles of Fc receptors in autoimmunity. Nat. Rev. Immunol. 2: 580-592. (Pubitemid 37328733)
37. Weaver, B. K., E. Bohn, B. A. Judd, M. P. Gil, and R. D. Schreiber. 2007. ABIN-3: a molecular basis for species divergence in interleukin-10-induced anti-inflammatory actions. Mol. Cell. Biol. 27: 4603-4616. (Pubitemid 47016116)
38. Wullaert, A., L. Verstrepen, S. Van Huffel, M. Adib-Conquy, S. Cornelis, M. Kreike, M. Haegman, K. El Bakkouri, M. Sanders, K. Verhelst, et al. 2007. LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-kappaB activation. J. Biol. Chem. 282: 81-90.
39. Rivero-Lezcano, O. M., C. González-Cortés, D. Reyes-Ruvalcaba, and C. Diez-Tascón. 2010. CCL20 is overexpressed in Mycobacterium tuberculosis-infected monocytes and inhibits the production of reactive oxygen species (ROS). Clin. Exp. Immunol. 162: 289-297.
40. Berger, S., R. Chandra, H. Balló, R. Hildenbrand, and H. J. Stutte. 1997. Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes. Eur. J. Immunol. 27: 2994-3000. (Pubitemid 27478373)
41. Polat, G. L., J. Laufer, I. Fabian, and J. H. Passwell. 1993. Cross-linking of monocyte plasma membrane Fc alpha, Fc gamma or mannose receptors induces TNF production. Immunology 80: 287-292. (Pubitemid 23308585)
42. Yuan, W., S. J. DiMartino, P. B. Redecha, L. B. Ivashkiv, and J. E. Salmon. 2011. Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes. Arthritis Rheum. 63: 212-218.
43. Baechler, E. C., F. M. Batliwalla, G. Karypis, P. M. Gaffney, W. A. Ortmann, K. J. Espe, K. B. Shark, W. J. Grande, K. M. Hughes, V. Kapur, et al. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 100: 2610-2615. (Pubitemid 36297546)
44. Bennett, L., A. K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197: 711-723. (Pubitemid 36350866)
45. Assassi, S., M. D. Mayes, F. C. Arnett, P. Gourh, S. K. Agarwal, T. A. McNearney, D. Chaussabel, N. Oommen, M. Fischbach, K. R. Shah, et al. 2010. Systemic sclerosis and lupus: points in an interferon-mediated continuum. Arthritis Rheum. 62: 589-598.
46. Garcia-Romo, G. S., S. Caielli, B. Vega, J. Connolly, F. Allantaz, Z. Xu, M. Punaro, J. Baisch, C. Guiducci, R. L. Coffman, et al. 2011. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3: 73ra20.
47. Lande, R., D. Ganguly, V. Facchinetti, L. Frasca, C. Conrad, J. Gregorio, S. Meller, G. Chamilos, R. Sebasigari, V. Riccieri, et al. 2011. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 3: 73ra19.
48. Stetson, D. B., J. S. Ko, T. Heidmann, and R. Medzhitov. 2008. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134: 587-598.
49. Harley, J. B., and J. A. James. 2006. Epstein-Barr virus infection induces lupus autoimmunity. Bull. NYU Hosp. Jt. Dis. 64: 45-50. (Pubitemid 44625532)
50. Nold, M. F., C. A. Nold-Petry, J. A. Zepp, B. E. Palmer, P. Bufler, and C. A. Dinarello. 2010. IL-37 is a fundamental inhibitor of innate immunity. Nat. Immunol. 11: 1014-1022.
51. Boulland,M. L., J. Marquet, V. Molinier-Frenkel, P. Möller, C. Guiter, F. Lasoudris, C. Copie-Bergman, M. Baia, P. Gaulard, K. Leroy, and F. Castellano. 2007. Human IL4I1 is a secreted L-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation. Blood 110: 220-227. (Pubitemid 47026838)
52. Marquet, J., F. Lasoudris, C. Cousin, M. L. Puiffe, N. Martin-Garcia, V. Baud, F. Chereau, J. P. Farcet, V. Molinier-Frenkel, and F. Castellano. 2010. Dichotomy between factors inducing the immunosuppressive enzyme IL-4-induced gene 1 (IL4I1) in B lymphocytes and mononuclear phagocytes. Eur. J. Immunol. 40: 2557-2568.
53. Oxer, D. S., L. C. Godoy, E. Borba, T. Lima-Salgado, L. A. Passos, I. Laurindo, S. Kubo, D. F. Barbeiro, D. Fernandes, F. R. Laurindo, et al. 2011. PPARγ expression is increased in systemic lupus erythematosus patients and represses CD40/CD40L signaling pathway. Lupus 20: 575-587.
54. Han, J. W., H. F. Zheng, Y. Cui, L. D. Sun, D. Q. Ye, Z. Hu, J. H. Xu, Z. M. Cai, W. Huang, G. P. Zhao, et al. 2009. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 41: 1234-1237.
55. He, C. F., Y. S. Liu, Y. L. Cheng, J. P. Gao, T. M. Pan, J. W. Han, C. Quan, L. D. Sun, H. F. Zheng, X. B. Zuo, et al. 2010. TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population. Lupus 19: 1181-1186.
56. Hahn, B. H. 2011. Targeted therapies in systemic lupus erythematosus: successes, failures and future. Ann. Rheum. Dis. 70(Suppl. 1): i64-i66.
57. Nguyen, V., C. Cudrici, V. Zernetkina, F. Niculescu, H. Rus, C. Drachenberg, and V. Rus. 2009. TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects. Clin. Immunol. 132: 32-42.
58. Benschop, R., T. Wei, and S. Na. 2009. Tumor necrosis factor receptor superfamily member 21: TNFR-related death receptor-6, DR6. Adv. Exp. Med. Biol. 647: 186-194.
59. Fischer, S., M. Nishio, S. Dadkhahi, J. Gansler, M. Saffarzadeh, A. Shibamiyama, N. Kral, N. Baal, T. Koyama, E. Deindl, and K. T. Preissner. 2011. Expression and localisation of vascular ribonucleases in endothelial cells. Thromb. Haemost. 105: 345-355.
60. Egesten, A., K. D. Dyer, D. Batten, J. B. Domachowske, and H. F. Rosenberg. 1997. Ribonucleases and host defense: identification, localization and gene expression in adherent monocytes in vitro. Biochim. Biophys. Acta 1358: 255-260. (Pubitemid 27462651)
61. Yang, D., Q. Chen, H. F. Rosenberg, S. M. Rybak, D. L. Newton, Z. Y. Wang, Q. Fu, V. T. Tchernev, M.Wang, B. Schweitzer, et al. 2004. Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation. J. Immunol. 173: 6134-6142. (Pubitemid 39487770)
62. Bovin, L. F., K. Rieneck, C. Workman, H. Nielsen, S. F. Sørensen, H. Skjødt, A. Florescu, S. Brunak, and K. Bendtzen. 2004. Blood cell gene expression profiling in rheumatoid arthritis: discriminative genes and effect of rheumatoid factor. Immunol. Lett. 93: 217-226. (Pubitemid 38670377)
63. Levy, N. T., W. F. Young, Jr., T. M. Habermann, J. G. Strickler, J. A. Carney, and A. W. Stanson. 1997. Adrenal insufficiency as a manifestation of disseminated non-Hodgkin's lymphoma. Mayo Clin. Proc. 72: 818-822. (Pubitemid 27382921)
64. Rosenberg, H. F., and K. D. Dyer. 1996. Molecular cloning and characterization of a novel human ribonuclease (RNase k6): increasing diversity in the enlarging ribonuclease gene family. Nucleic Acids Res. 24: 3507-3513. (Pubitemid 26315760)
65. Su, A. I., T. Wiltshire, S. Batalov, H. Lapp, K. A. Ching, D. Block, J. Zhang, R. Soden, M. Hayakawa, G. Kreiman, et al. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 101: 6062-6067. (Pubitemid 38520528)
66. Wu, C., C. Orozco, J. Boyer, M. Leglise, J. Goodale, S. Batalov, C. L. Hodge, J. Haase, J. Janes, J. W. Huss, III, and A. I. Su. 2009. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 10: R130.
67. Manderson, A. P., M. Botto, and M. J. Walport. 2004. The role of complement in the development of systemic lupus erythematosus. Annu. Rev. Immunol. 22: 431-456. (Pubitemid 38680429)
68. Moreau, A., M. Le Vee, E. Jouan, Y. Parmentier, and O. Fardel. 2011. Drug transporter expression in human macrophages. Fundam. Clin. Pharmacol. 25: 743-752.
69. Hornung, V., S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdörfer, T. Giese, S. Endres, and G. Hartmann. 2002. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531-4537. (Pubitemid 34441357)
70. Bekeredjian-Ding, I. B., M. Wagner, V. Hornung, T. Giese, M. Schnurr, S. Endres, and G. Hartmann. 2005. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J. Immunol. 174: 4043-4050. (Pubitemid 40395980)
71. Pascual, M., and J. A. Schifferli. 1992. The binding of immune complexes by the erythrocyte complement receptor 1 (CR1). Immunopharmacology 24: 101-106.